Clinical Trial Update: Pegfilgrastim in Patients With Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pegfilgrastim in patients with alcoholic hepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Timothy Morgan, MD | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED